Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants

Overview

This study will examine the safety and tolerability of supplementation with bovine lactoferrin with fructo-oligosaccharide a simple sugar in very low birth weight infants. Lactoferrin is a major whey protein in mother's milk and plays a role in promoting a mature and healthy gut. It also has antimicrobial and immunomodulation activities.

Aim 1: To evaluate the safety and tolerability of three different lactoferrin/FOS doses in preterm infants 1. Lactoferrin/FOS related adverse events and serious adverse events 2. Time reaching full feeds while receiving lactoferrin/FOS (120 ml/kg/day) 3. Episodes of not receiving enteral feedings for \> 24 hours once feeding is initiated Aim 2: To evaluate lactoferrin/FOS absorption and excretion 1. Examine lactoferrin/FOS levels in saliva, urine, plasma, and stool 2. Examine lactoferrin levels in materal and human donor milk Aim 3: To evaluate the effect of lactoferrin/FOS on the intestinal microbiome structure

Conditions

Interventions

Eligibility

Outcomes

Central Contacts